A Sub-Analysis of Taiwanese Patients From ODYSSEY South Korea and Taiwan Study Evaluating the Efficacy and Safety of Alirocumab

Journal of the Chinese Medical Association - Taiwan
doi 10.1097/jcma.0000000000000062
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Efficacy and Safety of Alirocumab in Patients With or Without Prior Coronary Revascularization: Pooled Analysis of Eight ODYSSEY Phase 3 Trials

Atherosclerosis
Cardiovascular MedicineCardiology
2018English

Efficacy and Safety of Levodopa–carbidopa Intestinal Gel From a Study in Japanese, Taiwanese, and Korean Advanced Parkinson’s Disease Patients

npj Parkinson's Disease
2016English

Efficacy and Safety of Alirocumab in Japanese Subjects (Phase 1 and 2 Studies)

American Journal of Cardiology
Cardiovascular MedicineCardiology
2016English

Prevalence of Overactive Bladder in China, Taiwan and South Korea: Results From a Cross-Sectional, Population-Based Study

LUTS: Lower Urinary Tract Symptoms
NeurologyUrology
2017English

Evaluating Safety and Efficacy of Functional Foods

Japanese Journal of Complementary and Alternative Medicine
2008English

The Viability of Fiscal Policy in South Korea, Taiwan, and Thailand

Asean Economic Bulletin
2002English

Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial†

Journal of Clinical Lipidology
Internal MedicineNutritionCardiologyEndocrinologyCardiovascular MedicineDieteticsMetabolismDiabetes
2019English

Efficacy and Safety of Indacaterol/Glycopyrronium in Japanese Patients With COPD: A Subgroup Analysis From the SHINE Study [Corrigendum]

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2017English

The Efficacy and Safety of Elbasvir/Grazoprevir Treatment in HCV Genotype 1 Patients in Taiwan

Journal of Medical Virology
VirologyInfectious Diseases
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy